tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

CRISM Therapeutics Launches £100,000 Retail Offer to Fund Clinical Trial

Story Highlights
CRISM Therapeutics Launches £100,000 Retail Offer to Fund Clinical Trial

TipRanks Cyber Monday Sale

Amur Minerals ( (GB:CRTX) ) just unveiled an announcement.

CRISM Therapeutics Corporation, a company involved in the healthcare and pharmaceuticals industry, has announced a retail offer to raise up to £100,000 through the issuance of new ordinary shares at 9 pence per share. This initiative is part of a broader strategy to fund its Phase 2 clinical trial of irinotecan-ChemoSeed for glioblastoma patients. The retail offer is available to UK investors and is coordinated by SP Angel Corporate Finance LLP. The completion of this offer is contingent upon the admission of the new shares to the AIM market of the London Stock Exchange.

More about Amur Minerals

Average Trading Volume: 74,298

Technical Sentiment Signal: Sell

Current Market Cap: £4.4M

For a thorough assessment of CRTX stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1